PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-01

Date Title Company
01-Oct-2024 Justera Health Signs Definitive Agreement To Acquire Popular Cannabis Brand, Port North AccessWire
01-Oct-2024 Muscle Lab Celebrates Grand Opening of Studio City Location on Ventura Blvd. AccessWire
01-Oct-2024 Legacy ER & Urgent Care Opens Seventh Dual Facility in Prosper, Texas on October 21 AccessWire
01-Oct-2024 BIOLASE Voluntarily Initiates Chapter 11 Proceedings AccessWire
01-Oct-2024 Cascade and Ottobock Announce Ownership Interest Change; an Independent Way Forward in Partnership AccessWire
01-Oct-2024 First Computer Chip in Spine Offers Hope, Opens Door for Injectable Therapies in Chronic Pain, Sleep Apnea, and Migraines AccessWire
01-Oct-2024 Elevate Clinical Research Solutions Announces Senior Director Nicole Bruecker AccessWire
01-Oct-2024 Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed Pentixapharm Holding AG
01-Oct-2024 How To Choose Between Veneers and Crowns for Your Cosmetic Needs AccessWire
01-Oct-2024 Glidewell Publishes Issue of Chairside(R) Magazine Dedicated to In-Office Digital Dentistry AccessWire
01-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma AG
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
01-Oct-2024 Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche Lonza Group AG
01-Oct-2024 OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software AccessWire
01-Oct-2024 Black Book IT Leader Survey Reveals 8 Technologies Draining Value From Health Systems AccessWire
01-Oct-2024 New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome AccessWire
01-Oct-2024 Heidelberg Pharma AG Announces Updated Guidance Heidelberg Pharma AG
01-Oct-2024 Lexaria Appoints Michael Shankman as Chief Financial Officer AccessWire
01-Oct-2024 Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia Kyowa Kirin